Author

S. Chaigne

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:imaging· 1

Frequent Co-Authors

A. Alafiatayo· 1 shared B. D. Stuyvers· 1 shared B. Quesson· 1 shared C. Bouchet· 1 shared D. El Hamrani· 1 shared E. Eyraud· 1 shared E. Maurat· 1 shared F. Brette· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Alafiatayo

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Increased spontaneous Ca2+ activity in Cardiac Purkinje cells after myocardial infarction; A consequence of a dramatic shift of SERCA isoforms as potential adaptation to acute ischemia?

B. D. Stuyvers, P. A. Boyden, R. Amin, L. L. Wiede, J. Dore, H. E. ter Keurs, W. Dun, Y. Guo, M. Haissaguerre, M. Hocini, F. Brette, O. Bernus, S. Chaigne, V. Loyer, J. Naulin, , T. Benoukraf

This study shows that increased spontaneous Ca2+ activity in cardiac Purkinje cells after myocardial infarction is due to a shift in SERCA2 isoforms, specifically increased SERCA2b and reduced SERCA2a.

bioRxiv · Oct 23, 2023 · PreprintCell Biology

CXCR4 blockade alleviates pulmonary and cardiac outcomes in early COPD

I. Dupin, P. Henrot, E. Maurat, R. Abohalaka, S. Chaigne, D. El Hamrani, E. Eyraud, R. Prevel, P. Esteves, M. Campagnac, M. Dubreuil, G. Cardouat, C. Bouchet, O. Ousova, J.-W. Dupuy, , P. Berger

This study shows that blocking CXCR4 improves lung and cardiac outcomes in early COPD using both human samples and mouse models.

bioRxiv · Mar 10, 2023Pathology